Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUTCH-WAIST
NCT06184633Phase 4Active, not recruiting
- Sponsor
- Rijnstate
- Start
- Jul 2024
- Primary completion
- Apr 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in Atrial fibrillation (AFib), obesity, sponsored by Rijnstate. Started Jul 2024; status: active, not recruiting.
02
Drugs
03
Conditions
Atrial fibrillation (AFib)obesity
Beyond the preview
Go deeper on NCT06184633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06184633.